Skip to main content

Advertisement

Log in

Comparative analysis of intracellular inhibition of hepatitis C virus replication by small interfering RNAs

  • Original Research Paper
  • Published:
Biotechnology Letters Aims and scope Submit manuscript

Abstract

Several synthetic siRNAs were designed to target various regions of hepatitis C virus (HCV) replicon RNA. The antiviral efficacies of the siRNAs were compared using real time PCR and western blot assessment. siRNAs targeting either specific coding region of HCV NS3 or NS5B were the most efficacious in terms of gene silencing and inhibitory activity of the HCV replicon replication. There was no activation of genes involved in innate immune response by the HCV-specific siRNA, indicating that HCV replication inhibition was not due to non-specific antiviral response. Moreover, 5′-RACE PCR analysis showed that the silencing effect by the siRNAs was mainly caused by specific cleavage of targeted HCV genomic RNA. These findings suggest that RNAi targeting HCV coding regions could provide a useful approach to anti-HCV treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Bartenschlager R, Frese M, Pietschmann T (2004) Novel insights into hepatitis C virus replication and persistence. Adv Virus Res 63:71–180

    Article  CAS  PubMed  Google Scholar 

  • Bernstein E, Causy AA, Hammond SM, Hannon GJ (2001) Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409:363–366

    Article  CAS  PubMed  Google Scholar 

  • Brown KM, Chu CY, Rana TM (2005) Target accessibility dictates the potency of Human RISC. Nat Struct Mol Biol 12:469–470

    Article  CAS  PubMed  Google Scholar 

  • De Francesco R (1999) Molecular virology of the hepatitis C virus. J Hepatol 312:47–53

    Article  Google Scholar 

  • Dykxhoorn DM, Lieberman J (2005) The silent revolution: RNA interference as basic biology, research tool, and therapeutic. Annu Rev Med 56:401–423

    Article  CAS  PubMed  Google Scholar 

  • Elbashir SM, Lendeckel W, Tuschl T (2001a) RNA interference is mediated by 21 and 22-nucleotide RNAs. Genes Dev 15:188–200

    Article  CAS  PubMed  Google Scholar 

  • Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001b) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cell. Nature 411:494–498

    Article  CAS  PubMed  Google Scholar 

  • Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806–811

    Article  CAS  PubMed  Google Scholar 

  • Hamilton AJ, Baulcombe DC (1999) A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 286:950–952

    Article  CAS  PubMed  Google Scholar 

  • Hugle T, Cerny A (2003) Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C. Rev Med Virol 13:361–371

    Article  PubMed  Google Scholar 

  • Kafasla P, Morgner N, Poyry TAA, Curry S, Robinson CV, Jackson RJ (2009) Polypyrimidine tract binding protein stabilizes the encephalomyocarditis virus IRES structure via binding multiple sites in a unique orientation. Mol Cell 34:556–568

    Article  CAS  PubMed  Google Scholar 

  • Khaliq S, Khaliq SA, Zahur M, Ijaz B, Jahan S, Ansar M, Riazuddin S, Hassan S (2010) RNAi as a new therapeutic strategy against HCV. Biotechnol Adv 28:27–34

    Article  CAS  PubMed  Google Scholar 

  • Krieger N, Lohmann V, Bartenschlager R (2001) Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J Virol 75:4614–4624

    Article  CAS  PubMed  Google Scholar 

  • Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345:41–52

    Article  CAS  PubMed  Google Scholar 

  • Lohmann V, Korner F, Koch JO, Herian U, Theilmann L, Bartenschlager R (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110–113

    Article  CAS  PubMed  Google Scholar 

  • Ryu KJ, Kim JH, Lee SW (2003) Ribozyme-mediated selective induction of new gene activity in hepatitis C virus internal ribosome entry site-expressing cells by targeted trans-splicing. Mol Ther 7:386–395

    Article  CAS  PubMed  Google Scholar 

  • Westerhout EM, Berkhout B (2007) A systematic analysis of the effect of target RNA structure on RNA interference. Nucleic Acid Res 35:4322–4330

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by grants from the Korea Healthcare Technology R&D Project by the Korean Ministry for Health, Welfare & Family Affairs (A080173). B. Chang, C. H. Lee, and J. H. Lee are recipients of Brain Korea 21 fellowship.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seong-Wook Lee.

Additional information

Purpose of work RNA interference (RNAi), a specific gene silencing process mediated by small interfering RNA (siRNA) duplexes, has been evaluated as a therapeutic tool against hepatitis C virus (HCV).

Byeongyong Chang and Chang Ho Lee contributed equally.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chang, B., Lee, C.H., Lee, J.H. et al. Comparative analysis of intracellular inhibition of hepatitis C virus replication by small interfering RNAs. Biotechnol Lett 32, 1231–1237 (2010). https://doi.org/10.1007/s10529-010-0298-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10529-010-0298-5

Keywords

Navigation